{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:39:25Z","timestamp":1783406365146,"version":"3.54.6"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.clon.2024.05.006","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T15:20:57Z","timestamp":1715613657000},"page":"e301-e311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Management Approaches in WHO Grade III Meningioma: A National Oncology Trainees' Collaborative for Healthcare Research (NOTCH) UK Multi-Centre Retrospective Study"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5976-385X","authenticated-orcid":false,"given":"C.B.","family":"Dobeson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5773-8650","authenticated-orcid":false,"given":"M.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8993-0148","authenticated-orcid":false,"given":"M.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6582-9632","authenticated-orcid":false,"given":"S.","family":"Kingdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4092-585X","authenticated-orcid":false,"given":"S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1715-3890","authenticated-orcid":false,"given":"K.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.I.","family":"Islim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7727-1157","authenticated-orcid":false,"given":"C.P.","family":"Millward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Clynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5390-9996","authenticated-orcid":false,"given":"S.M.","family":"Keshwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Eltinay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2305-3741","authenticated-orcid":false,"given":"L.","family":"Kviat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7297-8249","authenticated-orcid":false,"given":"R.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2442-4823","authenticated-orcid":false,"given":"P.A.","family":"Haris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9625-2111","authenticated-orcid":false,"given":"R.","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0040-0410","authenticated-orcid":false,"given":"S.","family":"Derby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0623-4636","authenticated-orcid":false,"given":"S.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kathirgamakarthigeyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4952-749X","authenticated-orcid":false,"given":"L.R.","family":"Narramneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2024.05.006_bib1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.clon.2024.05.006_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuchi.2016.05.001","article-title":"World Health Organization grade III meningiomas. A retrospective study for outcome and prognostic factors assessment","volume":"62","author":"Champeaux","year":"2016","journal-title":"Neurochirurgie"},{"key":"10.1016\/j.clon.2024.05.006_bib3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2024.05.006_bib4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.clon.2024.05.006_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11060-016-2318-3","article-title":"Epidemiology for primary brain tumors: a nationwide population-based study","volume":"131","author":"Darlix","year":"2017","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.clon.2024.05.006_bib6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ijrobp.2008.08.018","article-title":"Long-Term Experience With World Health Organization Grade III (Malignant) Meningiomas at a Single Institution","volume":"74","author":"Rosenberg","year":"2009","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.clon.2024.05.006_bib7","first-page":"2046","article-title":"\u201cMalignancy\u201d in meningiomas: a clinicopathologic study of 116 patients, with grading implications","volume":"85","author":"Perry","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2024.05.006_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-4608(98)00209-X","article-title":"Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas","volume":"110","author":"Lamszus","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.clon.2024.05.006_bib9","first-page":"665","article-title":"Incidence and clinicopathological features of meningioma","volume":"71","author":"Rohringer","year":"1989","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.clon.2024.05.006_bib10","doi-asserted-by":"crossref","first-page":"11220","DOI":"10.1038\/s41598-020-68177-x","article-title":"Histological transformation in recurrent WHO grade I meningiomas","volume":"10","author":"Corniola","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.clon.2024.05.006_bib11","first-page":"925","article-title":"A\u00a0comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas","volume":"112","author":"McGovern","year":"2010","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.clon.2024.05.006_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00701-012-1611-y","article-title":"Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases","volume":"155","author":"Cornelius","year":"2013","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.clon.2024.05.006_bib13","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1007\/BF01809747","article-title":"Metastasis in meningioma","volume":"138","author":"Enam","year":"1996","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.clon.2024.05.006_bib14","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","article-title":"EANO guidelines for the diagnosis and treatment of meningiomas","volume":"17","author":"Goldbrunner","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2024.05.006_bib15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0360-3016(95)02166-3","article-title":"Radiotherapy for atypical or malignant intracranial meningioma","volume":"34","author":"Milosevic","year":"1996","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.clon.2024.05.006_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ijrobp.2008.08.018","article-title":"Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution","volume":"74","author":"Rosenberg","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2024.05.006_bib17","first-page":"1684","article-title":"Anaplastic meningioma: an analysis of the National Cancer Database from 2004 to 2012","volume":"128","author":"Orton","year":"2018","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.clon.2024.05.006_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1005853720926","article-title":"Malignant meningioma: An indication for initial aggressive surgery and adjuvant radiotherapy","volume":"37","author":"Dziuk","year":"1998","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.clon.2024.05.006_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11060-014-1507-1","article-title":"Efficacy of postoperative radiotherapy for high grade meningiomas","volume":"119","author":"Choi","year":"2014","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.clon.2024.05.006_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-020-03674-7","article-title":"Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas","volume":"152","author":"Unterberger","year":"2021","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.clon.2024.05.006_bib21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s003300050466","article-title":"Dural invasion of meningiomas adjacent to the tumor margin on Gd-DTPA-enhanced MR images: histopathologic correlation","volume":"8","author":"Hutzelmann","year":"1998","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clon.2024.05.006_bib22","doi-asserted-by":"crossref","first-page":"i67","DOI":"10.1093\/noajnl\/vdac088","article-title":"Radiotherapy and radiosurgery for meningiomas","volume":"5","author":"Chen","year":"2023","journal-title":"Neuro-Oncology Adv"},{"key":"10.1016\/j.clon.2024.05.006_bib23","first-page":"202","article-title":"Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas","volume":"113","author":"Sughrue","year":"2010","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.clon.2024.05.006_bib24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijrobp.2018.05.011","article-title":"Radiologic Response and Disease Control of Recurrent Intracranial Meningiomas Treated With Reirradiation","volume":"102","author":"Lin","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2024.05.006_bib25","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.2007","article-title":"Trabectedin for recurrent WHO grade II or III meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)","volume":"37","author":"Preusser","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2024.05.006_bib26","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1215\/15228517-2009-010","article-title":"Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)","volume":"11","author":"Wen","year":"2009","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.clon.2024.05.006_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11060-009-9948-7","article-title":"Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma","volume":"96","author":"Norden","year":"2010","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.clon.2024.05.006_bib28","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1200\/JCO.2015.61.6490","article-title":"Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005","volume":"33","author":"Ji","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2024.05.006_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11060-011-0741-z","article-title":"Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma","volume":"107","author":"Chamberlain","year":"2012","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.clon.2024.05.006_bib30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00280-014-2422-z","article-title":"Recurrent high-grade meningioma: a phase II trial with somatostatin analogue therapy","volume":"73","author":"Sim\u00f3","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.clon.2024.05.006_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/neuonc\/nou148","article-title":"Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma","volume":"17","author":"Kaley","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.clon.2024.05.006_bib32","doi-asserted-by":"crossref","first-page":"v130.4","DOI":"10.1093\/neuonc\/nov220.04","article-title":"MNGO-04PHASE II TRIAL OF BEVACIZUMAB IN PATIENTS WITH SURGERY AND RADIATION REFRACTORY PROGRESSIVE MENINGIOMA","volume":"17","author":"Grimm","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.clon.2024.05.006_bib33","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/1078-0432.CCR-19-2109","article-title":"Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial","volume":"26","author":"Graillon","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clon.2024.05.006_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/08880018.2014.936058","article-title":"Metastatic Rhabdoid Meningioma with BRAF V600E Mutation and Good Response to Personalized Therapy: Case Report and Review of the Literature","volume":"32","author":"Mordechai","year":"2015","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.clon.2024.05.006_bib35","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.clon.2020.05.005","article-title":"Trainee Board of the National Oncology Trainees Collaborative for Healthcare Research. NOTCH: The National Oncology Trainees Collaborative for Healthcare Research","volume":"32","author":"Jones","year":"2020","journal-title":"Clin Oncol (R Coll Radiol"},{"key":"10.1016\/j.clon.2024.05.006_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000338081","article-title":"Epidemiology of Meningioma in the United Kingdom","volume":"39","author":"Cea-Soriano","year":"2012","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.clon.2024.05.006_bib37","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1750-3639.2007.00084.x","article-title":"The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities","volume":"17","author":"Fuller","year":"2007","journal-title":"Brain Pathol"},{"key":"10.1016\/j.clon.2024.05.006_bib38","doi-asserted-by":"crossref","DOI":"10.3171\/foc.1997.2.4.6","article-title":"Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases","volume":"2","author":"Palma","year":"1997","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.clon.2024.05.006_bib39","first-page":"393","article-title":"Grade 3 meningioma survival and recurrence outcomes in an international multicenter cohort","volume":"140","author":"Tosefsky","year":"2024","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.clon.2024.05.006_bib40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.radonc.2018.06.018","article-title":"Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042)","volume":"128","author":"Weber","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2024.05.006_bib41","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ijrobp.2023.09.026","article-title":"Dose-Escalated Radiation Therapy Is Associated With Improved Outcomes for High-Grade Meningioma","volume":"118","author":"Zeng","year":"2024","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.clon.2024.05.006_bib42","article-title":"Radiotherapy intensification for atypical and malignant meningiomas: A systematic review","author":"Gaito","year":"2023","journal-title":"Neuro-Oncology Pract"},{"key":"10.1016\/j.clon.2024.05.006_bib43","first-page":"1447","article-title":"Meningioma metastases: incidence and proposed screening paradigm","volume":"132","author":"Dalle Ore","year":"2019","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.clon.2024.05.006_bib44","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11060-020-03604-7","article-title":"Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry","volume":"149","author":"Brown","year":"2020","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.clon.2024.05.006_bib45","doi-asserted-by":"crossref","first-page":"E461","DOI":"10.1093\/neuros\/nyy610","article-title":"Malignant Meningioma: An International Multicentre Retrospective Study","volume":"85","author":"Champeaux","year":"2019","journal-title":"Neurosurgery"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093665552400181X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093665552400181X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T06:35:53Z","timestamp":1730097353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093665552400181X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S093665552400181X"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2024.05.006","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management Approaches in WHO Grade III Meningioma: A National Oncology Trainees' Collaborative for Healthcare Research (NOTCH) UK Multi-Centre Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2024.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Ltd on behalf of The Royal College of Radiologists. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}